| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |